Effectiveness of an Inspiratory Muscle Training in Patients Receiving Allogenic Stem Cell Transplantation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Inspiratory Muscle Training
- Sponsor
- Elisabethinen Hospital
- Enrollment
- 106
- Locations
- 1
- Primary Endpoint
- Change of PI max-value from baseline at 30 days after stem cell transplantation
- Last Updated
- 14 years ago
Overview
Brief Summary
The study is a monocentric, controlled randomized trial. Its an interventional method study. There is a control and an interventional group. The interventional group is receiving a specific inspiratory muscle training with "Respifit" (special device for inspiratory muscle training) during the first 30 days after allogenic stem cell transplantation.
The investigators want to show that the training group gets stronger inspiratory muscles. The investigators measure the change of PIMAX values and MVV values.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients receiving allogenic stem cell transplantation
- •Age 17 - 80 years old
- •Informed consent
Exclusion Criteria
- •Actual pneumonia at the beginning of the trial
- •Impaired vision
- •Patient is not able to handle "Respifit"
Outcomes
Primary Outcomes
Change of PI max-value from baseline at 30 days after stem cell transplantation
Time Frame: baseline and 30 days after stem cell transplantation
max strength of the inspiratory muscles
Change of MVV-value from baseline at 30 days after transplantation
Time Frame: baseline and 30 days after stem cell transplantation
max voluntary volume for Inspiratory muscle endurance
Secondary Outcomes
- inpatient days(from baseline to maximal 60 days after stem cell transplantation)
- Incidence of pneumonia(from baseline to 30 days after stem cell transplantation)